Government data released this week shows that the ongoing Ebola outbreak in the Democratic Republic of Congo (DRC) has claimed more than 5,000 lives and recorded over 10,300 confirmed infections. The disease, caused by the Bundibugyo strain, has spread to eight of the country’s 26 provinces, with the epicentre remaining in the conflict‑ridden Ituri province in the northeast.
Outbreak scope and impact
The epidemic began in May and, according to public health officials, became the deadliest in DRC history in August. The current case‑fatality rate stands at 48.6 percent. The United Nations (UN) notes that this is the 17th Ebola outbreak in the nation and the second largest on record, trailing only the 2014‑2016 West African crisis that killed more than 11,300 people across several countries.
DRC’s previous deadliest episode, which lasted from 2018 to 2020, resulted in 2,299 deaths. By contrast, the present outbreak is “taking lives at a much faster rate,” the UN warned. Symptoms of Ebola include sudden onset of fever, vomiting, diarrhoea, and in severe cases, internal and external bleeding, organ failure, and death. Transmission occurs through direct contact with infected bodily fluids such as blood or vomit.
Regional spread and response
Beyond the DRC, confirmed cases have emerged in Kenya, Nigeria and Uganda. Kenya has reported nine confirmed infections and two deaths. Nigeria identified two suspected cases on a Saturday; both individuals were isolated and are undergoing testing. Earlier in October, a Nigerian woman diagnosed with Ebola was evacuated to Switzerland for treatment.
Uganda recorded two deaths and 20 cases shortly after the outbreak’s start, but no new infections have been reported since August. Travel restrictions remain in place for anyone crossing from the DRC into Uganda. The World Health Organization’s Africa office called for a “continued scale‑up of key control measures, greater access to affected areas, and community outreach” to halt the spread. Testing, treatment and clinical vaccine trials are underway, although no approved vaccine or specific treatment exists for the Bundibugyo strain.
Security challenges and community response
Efforts to contain the virus have been hampered by violence. Health workers and a politician have been attacked while responding to the crisis. Earlier this week, a nurse was killed and another health worker seriously injured after local youths accused them of contaminating water sources. Last month, a politician advocating for Ebola control measures was beaten to death.
In August, the Red Cross reported that its volunteers were injured and an ambulance was set on fire in 11 violent incidents during the outbreak’s first 100 days. Such attacks underscore the difficulty of delivering care in conflict zones like Ituri.
The European Centre for Disease Prevention and Control (ECDC) has stated that the likelihood of Ebola infection in Europe remains “very low.” Nevertheless, the UN and WHO continue to emphasize the urgency of scaling up interventions, improving access to hard‑to‑reach areas, and engaging communities to overcome misinformation and resistance.
As the outbreak progresses, the international health community watches closely, balancing the need for rapid vaccine trials with the imperative to protect frontline workers and restore trust among affected populations.
Helene Elliott is the Lead Science & Space Reporter at News Raise. She reports on aerospace missions, astrophysics discoveries, quantum research, and environmental technology.
